Molecular subtyping of invasive bladder cancer: time to divide and rule?
- PMID: 24525229
- DOI: 10.1016/j.ccr.2014.01.026
Molecular subtyping of invasive bladder cancer: time to divide and rule?
Abstract
Therapeutic decisions for muscle-invasive bladder cancer (MIBC) are largely based on histopathologic characteristics. In this issue of Cancer Cell, Choi and colleagues report three molecular subtypes of MIBC with the potential to guide prognosis, patient stratification, and treatment.
Copyright © 2014 Elsevier Inc. All rights reserved.
Comment on
-
Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy.Cancer Cell. 2014 Feb 10;25(2):152-65. doi: 10.1016/j.ccr.2014.01.009. Cancer Cell. 2014. PMID: 24525232 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous